State Board of Administration of Florida Retirement System’s Aimmune Therapeutics AIMT Stock Holding History
Bought
Maintained
Sold
State Board of Administration of Florida Retirement System's AIMT Position: Q4 2020 in Review
State Board of Administration of Florida Retirement System sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 28,862 shares — an estimated $994K sold.
State Board of Administration of Florida Retirement System first reported a position in AIMT in Q4 2017 and held it in 12 quarters. The position peaked at $994K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.
- State Board of Administration of Florida Retirement System reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
- State Board of Administration of Florida Retirement System sold 28,862 Aimmune Therapeutics shares in Q4 2020, an estimated $994K.
- State Board of Administration of Florida Retirement System first reported a position in Aimmune Therapeutics in Q4 2017 and held it in 12 quarters.
- State Board of Administration of Florida Retirement System's Aimmune Therapeutics position peaked at $994K in Q3 2020.
- 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.
Based on State Board of Administration of Florida Retirement System's 13F filing for Q4 2020, filed 8 Feb 2021.